secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001999371-25-005717
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tonix shareholders approve reverse stock split authorization and stock plan amendments at annual meeting
--------------------------------------------------------------------------------

- Reverse stock split authorized at ratio between 1:2 and 1:250, with 1,764,316 for, 1,203,561 against.
- Stock incentive plan amended to increase shares by 1,000,000; 751,420 votes for, 724,627 against.
- 2025 Employee Stock Purchase Plan approved with 1,134,671 votes for, 249,372 against.
- Say-on-pay proposal approved with 1,045,066 votes for; frequency set to every three years.
- All 8 director nominees elected; auditor EisnerAmper LLP ratified with 2,812,075 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125005717/0001999371-25-005717-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125005717/tnxp-8k_050825.htm
  HTML page:      https://secwatch.observer/filing/0001999371-25-005717

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer